It is now well established that ventilating patients with acute lung injury (ALI) and the acute respiratory distress syndrome (ARDS) using a strategy that limits alveolar distending volume and end-inspiratory static airway pressure results in improved survival, as compared to larger-volume, higher-pressure ventilation.
This multicenter randomized trialnicknamed the VISEP studyused a two-by-two factorial design to test two independent treatments in severe sepsis patients.
In this issue: Does erythropoietin worsen cancer death rates? Most hypothyroid patients can be replaced with levothyroxine alone without additional T3. Does aggressive control in type 2 diabetes save lives?
Most cases of thrombocytopenia seen are expected. Patients are known to have hematological disease or are receiving chemotherapy. At times, however, the physician is confronted with an unexpected laboratory finding in an asymptomatic patient, or with a patient who is bleeding. The challenge, as usual, is to determine the need for acute treatment and the appropriate disposition.
Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.
There has been recent emphasis in cardiology literature highlighting the importance of recognizing a new sub-specialty within the field, aimed at treating adult patients who have survived after having congenital heart disease repair.
